Cipla Global

Rediff.com » News » Cipla Global

News for Cipla Global

News
Business

Cipla ready to partner in Covid vaccine distribution

However, Cipla was very clear it does not want to get into vaccine manufacturing. Sohini Das reports. IMAGE: Healthcare workers wearing PPE kits carry syringes towards a Covid-19......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Several firms are stepping up to help their workforce cope with soaring temperatures. IMAGE: Workers drink water as they take a break at a construction site on a hot summer day in New Delhi, May......

Why Is USFDA Inspecting India Pharma Firms?

Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......

India may get 4m doses of Pfizer, Moderna by August from COVAX

However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini......

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. Photograph: Danish Siddiqui/Reuters......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Factors that will guide the markets this week

In an event-heavy week, stock investors will track ongoing quarterly earnings, the US Federal Reserve's interest rate decision, and macroeconomic data for market direction, analysts said.......

Indian Pharma Majors Ready With Weight Loss Drugs

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly. Kindly note the image has been posted only for representational purposes.......

Messiah of the masses: Cipla's global crusade for low cost drugs

In 1935, when Khwaja Abdul Hamied set up Cipla in Central Mumbai to manufacture medicines in India, few could have predicted that in the next few decades the company would take on the world's......

Cipla Global

News for Cipla Global

Cipla ready to partner in Covid vaccine distribution

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Why Is USFDA Inspecting India Pharma Firms?

India may get 4m doses of Pfizer, Moderna by August from COVAX

Cipla Q2 profit up 3.7% at Rs 1,353 cr

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Factors that will guide the markets this week

Indian Pharma Majors Ready With Weight Loss Drugs

Messiah of the masses: Cipla's global crusade for low cost drugs

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS